BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27391060)

  • 1. Inhibition of canonical WNT/β-catenin signaling is involved in leflunomide (LEF)-mediated cytotoxic effects on renal carcinoma cells.
    Chen Y; Huang Q; Zhou H; Wang Y; Hu X; Li T
    Oncotarget; 2016 Aug; 7(31):50401-50416. PubMed ID: 27391060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrvinium Sensitizes Clear Cell Renal Cell Carcinoma Response to Chemotherapy Via Casein Kinase 1α-Dependent Inhibition of Wnt/β-Catenin.
    Cui L; Zhao J; Liu J
    Am J Med Sci; 2018 Mar; 355(3):274-280. PubMed ID: 29549930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Wnt3a-mediated nuclear beta-catenin accumulation and activation by integrin-linked kinase in mammalian cells.
    Oloumi A; Syam S; Dedhar S
    Oncogene; 2006 Dec; 25(59):7747-57. PubMed ID: 16799642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
    Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
    Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
    Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
    Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.
    Cho YD; Kim WJ; Yoon WJ; Woo KM; Baek JH; Lee G; Kim GS; Ryoo HM
    J Cell Physiol; 2012 Jun; 227(6):2287-96. PubMed ID: 22213482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
    Parr C; Mirzaei N; Christian M; Sastre M
    FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
    Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M
    Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy.
    Bi Y; Jiang Y; Li X; Hou G; Li K
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):499-505. PubMed ID: 33225417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
    Yang F; Zeng Q; Yu G; Li S; Wang CY
    Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML.
    Ma S; Yang LL; Niu T; Cheng C; Zhong L; Zheng MW; Xiong Y; Li LL; Xiang R; Chen LJ; Zhou Q; Wei YQ; Yang SY
    Sci Rep; 2015 Oct; 5():15646. PubMed ID: 26497577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
    Von Schulz-Hausmann SA; Schmeel LC; Schmeel FC; Schmidt-Wolf IG
    Anticancer Res; 2014 Aug; 34(8):4101-8. PubMed ID: 25075035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by chondroitin sulfate E can specify functional Wnt/β-catenin signaling thresholds in NIH3T3 fibroblasts.
    Willis CM; Klüppel M
    J Biol Chem; 2012 Oct; 287(44):37042-56. PubMed ID: 22915582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
    Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor tyrosine kinase-like orphan receptor 2 (Ror2) expression creates a poised state of Wnt signaling in renal cancer.
    Rasmussen NR; Wright TM; Brooks SA; Hacker KE; Debebe Z; Sendor AB; Walker MP; Major MB; Green J; Wahl GM; Rathmell WK
    J Biol Chem; 2013 Sep; 288(36):26301-26310. PubMed ID: 23893409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta.
    Bikkavilli RK; Feigin ME; Malbon CC
    J Cell Sci; 2008 Nov; 121(Pt 21):3598-607. PubMed ID: 18946023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dickkopf-1 mediated tumor suppression in human breast carcinoma cells.
    Mikheev AM; Mikheeva SA; Maxwell JP; Rivo JV; Rostomily R; Swisshelm K; Zarbl H
    Breast Cancer Res Treat; 2008 Nov; 112(2):263-73. PubMed ID: 18157634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.